Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy
Background: Impaired coronary flow reserve (CFR) is a significant predictor of poor prognosis in patients with idiopathic dilated cardiomyopathy (IDC). Nebivolol reduces mortality and morbidity in patients with heart failure and left ventricular dysfunction, including cases caused by IDC. Objective:...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2010-10-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2124 |
| _version_ | 1797882673241260032 |
|---|---|
| author | Dogan Erdogan Hakan Gullu Mustafa Caliskan Ozgur Ciftci Semra Baycan Aylin Yildirir Haldun Muderrisoglu |
| author_facet | Dogan Erdogan Hakan Gullu Mustafa Caliskan Ozgur Ciftci Semra Baycan Aylin Yildirir Haldun Muderrisoglu |
| author_sort | Dogan Erdogan |
| collection | DOAJ |
| description | Background: Impaired coronary flow reserve (CFR) is a significant predictor of poor prognosis in patients with idiopathic dilated cardiomyopathy (IDC). Nebivolol reduces mortality and morbidity in patients with heart failure and left ventricular dysfunction, including cases caused by IDC. Objective: To assess the effects of nebivolol on CFR in patients with IDC. Methods: CFR was measured in the main group (MG), including 21 clinically stable patients with IDC (mean (SD) ejection fraction 35,7 (6,2)), at baseline and after 1 month of treatment with nebivolol once daily. A control group (CG) of apparently healthy subjects who were matched for age and sex was used for comparison. Resting and hyperaemic coronary flows were measured using transthoracic second-harmonic Doppler echocardiography. None of the subjects had any systemic disease. Results: After 1 month of treatment, heart rate (HR) was reduced significantly (p<0,001). The blood pressure (BP) was decreased significantly (p<0,001). The left ventricular end-diastolic diameter and stroke volume were not changed significantly, but end-systolic diameter was decreased significantly (p<0,05). Resting rate–pressure product was lower after treatment with nebivolol, but dipyridamole-induced change was not influenced by the treatment. Nebivolol treatment significantly reduced coronary velocities at rest (p<0,02) and also caused a significant increase in coronary velocities after dipyridamole (p<0,02), leading to a greater CFR (2,02 (0,35) vs. 2,61 (0,43); p<0,001). Nebivolol induced an absolute increase of at least 6% in the CFR in 17 of 21 patients (80,9%). Conclusions: In patients with IDC, 1 month of treatment with nebivolol induces a marked increase in CFR. |
| first_indexed | 2024-04-10T03:38:26Z |
| format | Article |
| id | doaj.art-78d11287196447dfb72fc432b002e908 |
| institution | Directory Open Access Journal |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| last_indexed | 2024-04-10T03:38:26Z |
| publishDate | 2010-10-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj.art-78d11287196447dfb72fc432b002e9082023-03-13T07:23:18Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252010-10-019559651833Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathyDogan Erdogan0Hakan Gullu1Mustafa Caliskan2Ozgur Ciftci3Semra Baycan4Aylin Yildirir5Haldun Muderrisoglu6Cardiology Department, Konya Teaching and Medical Research Center, Baskent University, KonyaCardiology Department, Konya Teaching and Medical Research Center, Baskent University, KonyaCardiology Department, Konya Teaching and Medical Research Center, Baskent University, KonyaCardiology Department, Konya Teaching and Medical Research Center, Baskent University, KonyaCardiology Department, Konya Teaching and Medical Research Center, Baskent University, KonyaCardiology Department, Konya Teaching and Medical Research Center, Baskent University, KonyaCardiology Department, Konya Teaching and Medical Research Center, Baskent University, KonyaBackground: Impaired coronary flow reserve (CFR) is a significant predictor of poor prognosis in patients with idiopathic dilated cardiomyopathy (IDC). Nebivolol reduces mortality and morbidity in patients with heart failure and left ventricular dysfunction, including cases caused by IDC. Objective: To assess the effects of nebivolol on CFR in patients with IDC. Methods: CFR was measured in the main group (MG), including 21 clinically stable patients with IDC (mean (SD) ejection fraction 35,7 (6,2)), at baseline and after 1 month of treatment with nebivolol once daily. A control group (CG) of apparently healthy subjects who were matched for age and sex was used for comparison. Resting and hyperaemic coronary flows were measured using transthoracic second-harmonic Doppler echocardiography. None of the subjects had any systemic disease. Results: After 1 month of treatment, heart rate (HR) was reduced significantly (p<0,001). The blood pressure (BP) was decreased significantly (p<0,001). The left ventricular end-diastolic diameter and stroke volume were not changed significantly, but end-systolic diameter was decreased significantly (p<0,05). Resting rate–pressure product was lower after treatment with nebivolol, but dipyridamole-induced change was not influenced by the treatment. Nebivolol treatment significantly reduced coronary velocities at rest (p<0,02) and also caused a significant increase in coronary velocities after dipyridamole (p<0,02), leading to a greater CFR (2,02 (0,35) vs. 2,61 (0,43); p<0,001). Nebivolol induced an absolute increase of at least 6% in the CFR in 17 of 21 patients (80,9%). Conclusions: In patients with IDC, 1 month of treatment with nebivolol induces a marked increase in CFR.https://cardiovascular.elpub.ru/jour/article/view/2124 |
| spellingShingle | Dogan Erdogan Hakan Gullu Mustafa Caliskan Ozgur Ciftci Semra Baycan Aylin Yildirir Haldun Muderrisoglu Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy Кардиоваскулярная терапия и профилактика |
| title | Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy |
| title_full | Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy |
| title_fullStr | Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy |
| title_full_unstemmed | Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy |
| title_short | Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy |
| title_sort | nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy |
| url | https://cardiovascular.elpub.ru/jour/article/view/2124 |
| work_keys_str_mv | AT doganerdogan nebivololimprovescoronaryflowreserveinpatientswithidiopathicdilatedcardiomyopathy AT hakangullu nebivololimprovescoronaryflowreserveinpatientswithidiopathicdilatedcardiomyopathy AT mustafacaliskan nebivololimprovescoronaryflowreserveinpatientswithidiopathicdilatedcardiomyopathy AT ozgurciftci nebivololimprovescoronaryflowreserveinpatientswithidiopathicdilatedcardiomyopathy AT semrabaycan nebivololimprovescoronaryflowreserveinpatientswithidiopathicdilatedcardiomyopathy AT aylinyildirir nebivololimprovescoronaryflowreserveinpatientswithidiopathicdilatedcardiomyopathy AT haldunmuderrisoglu nebivololimprovescoronaryflowreserveinpatientswithidiopathicdilatedcardiomyopathy |